Published in Proc Natl Acad Sci U S A on August 03, 2010
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Concurrent activation of striatal direct and indirect pathways during action initiation. Nature (2013) 4.87
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci (2010) 3.02
The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front Neuroanat (2011) 1.87
Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat (2011) 1.85
Differential innervation of direct- and indirect-pathway striatal projection neurons. Neuron (2013) 1.69
Cell-Type-Specific Sensorimotor Processing in Striatal Projection Neurons during Goal-Directed Behavior. Neuron (2015) 1.61
Cell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia. Cell (2016) 1.52
Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions. EMBO J (2011) 1.40
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. Front Behav Neurosci (2011) 1.30
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev (2011) 1.29
Striatal microcircuitry and movement disorders. Trends Neurosci (2012) 1.22
Dopamine signaling in reward-related behaviors. Front Neural Circuits (2013) 1.21
What is the Degree of Segregation between Striatonigral and Striatopallidal Projections? Front Neuroanat (2010) 1.21
Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord (2011) 1.18
An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons. Front Syst Neurosci (2011) 1.15
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. J Neural Transm (Vienna) (2011) 1.12
Neuroscience: To go or not to go. Nature (2013) 1.11
Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons. Front Neuroanat (2011) 1.10
Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action. Proc Natl Acad Sci U S A (2012) 1.10
DARPP-32, Jack of All Trades… Master of Which? Front Behav Neurosci (2011) 1.09
Long term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through kappa-opioid receptors. J Physiol (2017) 1.08
Integrating synaptic plasticity and striatal circuit function in addiction. Curr Opin Neurobiol (2011) 1.08
Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization. Proc Natl Acad Sci U S A (2011) 1.06
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc Natl Acad Sci U S A (2010) 1.05
Antagonistic but Not Symmetric Regulation of Primary Motor Cortex by Basal Ganglia Direct and Indirect Pathways. Neuron (2015) 1.05
Reassessing models of basal ganglia function and dysfunction. Annu Rev Neurosci (2014) 1.04
Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action. J Neurosci (2015) 1.02
Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos Trans R Soc Lond B Biol Sci (2012) 1.02
Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases. Front Neuroanat (2011) 1.02
Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. Front Neuroanat (2011) 1.01
Ethanol-mediated facilitation of AMPA receptor function in the dorsomedial striatum: implications for alcohol drinking behavior. J Neurosci (2012) 1.00
D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. J Neurosci (2013) 0.98
G9a influences neuronal subtype specification in striatum. Nat Neurosci (2014) 0.98
Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology (2011) 0.96
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96
Ras-ERK Signaling in Behavior: Old Questions and New Perspectives. Front Behav Neurosci (2011) 0.96
Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat. J Pharmacol Exp Ther (2011) 0.95
Targeting neuronal populations of the striatum. Front Neuroanat (2011) 0.94
Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med (2012) 0.94
Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMC Neurosci (2011) 0.93
Investigating striatal function through cell-type-specific manipulations. Neuroscience (2011) 0.92
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog Neurobiol (2015) 0.92
What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiol Dis (2013) 0.92
Neuromodulatory control of striatal plasticity and behavior. Curr Opin Neurobiol (2011) 0.91
Striatal direct and indirect pathways control decision-making behavior. Front Psychol (2014) 0.90
Unraveling the differential functions and regulation of striatal neuron sub-populations in motor control, reward, and motivational processes. Front Behav Neurosci (2011) 0.90
The basal ganglia, the ideal machinery for the cost-benefit analysis of action plans. Front Neural Circuits (2013) 0.89
An adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic stroke. J Neurosci (2014) 0.88
Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: in vivo optical microprobe [Ca2+]i imaging. J Neurosci (2011) 0.88
Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation. PLoS One (2013) 0.86
Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. Proc Natl Acad Sci U S A (2016) 0.85
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat Commun (2013) 0.85
Neuromodulation of excitatory synaptogenesis in striatal development. Elife (2015) 0.84
Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Front Neuroanat (2011) 0.84
Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain. Biol Psychiatry (2013) 0.84
Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence. Front Psychiatry (2013) 0.84
Dopamine systems adaptation during acquisition and consolidation of a skill. Front Integr Neurosci (2014) 0.84
Past, present, and future of the pathophysiological model of the Basal Ganglia. Front Neuroanat (2011) 0.83
Selective expression of a dominant-negative type Iα PKA regulatory subunit in striatal medium spiny neurons impairs gene expression and leads to reduced feeding and locomotor activity. J Neurosci (2014) 0.83
Neurobehavioral phenotyping of G(αq) knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair. Front Behav Neurosci (2012) 0.83
Dopaminergic presynaptic modulation of nigral afferents: its role in the generation of recurrent bursting in substantia nigra pars reticulata neurons. Front Syst Neurosci (2011) 0.83
Dopaminergic modulation of corticostriatal responses in medium spiny projection neurons from direct and indirect pathways. Front Syst Neurosci (2011) 0.83
Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice. Neuroscience (2013) 0.83
Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials. Neurotherapeutics (2011) 0.83
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats. ACS Chem Neurosci (2013) 0.81
mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. J Neurosci (2015) 0.81
Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions. Neuropsychopharmacology (2014) 0.81
A role for kalirin in the response of rat medium spiny neurons to cocaine. Mol Pharmacol (2012) 0.81
The arbitration-extension hypothesis: a hierarchical interpretation of the functional organization of the Basal Ganglia. Front Syst Neurosci (2011) 0.81
Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease. Parkinsons Dis (2012) 0.81
Protein kinase D1-dependent phosphorylation of dopamine D1 receptor regulates cocaine-induced behavioral responses. Neuropsychopharmacology (2013) 0.80
C. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behavior. PLoS Genet (2012) 0.80
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology (2015) 0.80
Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. PLoS Genet (2014) 0.80
Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. Front Pharmacol (2014) 0.80
Identification of optogenetically activated striatal medium spiny neurons by Npas4 expression. PLoS One (2012) 0.80
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration. BMC Neurosci (2013) 0.79
The substantia nigra conveys target-dependent excitatory and inhibitory outputs from the basal ganglia to the thalamus. J Neurosci (2014) 0.79
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease. Proc Natl Acad Sci U S A (2015) 0.78
Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32(1,2,3). eNeuro (2015) 0.78
Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice. Brain Res (2012) 0.78
A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans. Front Hum Neurosci (2016) 0.77
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. J Neurosci (2015) 0.77
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia. Parkinsons Dis (2012) 0.77
Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice. J Neurophysiol (2013) 0.77
Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling. Neuron (2016) 0.77
Segregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulants. PLoS Comput Biol (2014) 0.77
Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum. Exp Neurobiol (2011) 0.77
Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. Neuropsychopharmacology (2014) 0.77
GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors. eNeuro (2016) 0.77
Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function. Biol Psychiatry (2013) 0.76
Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression. ISRN Neurol (2012) 0.76
Conditional targeting of medium spiny neurons in the striatal matrix. Front Behav Neurosci (2015) 0.75
Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice. J Neurochem (2015) 0.75
Cocaine-induced behavioral sensitization in mice: effects of microinjection of dopamine d2 receptor antagonist into the nucleus accumbens. Exp Neurobiol (2013) 0.75
Psychostimulants and movement disorders. Front Neurol (2015) 0.75
Targeting the D1-N-methyl-d-aspartate receptor complex reduces l-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats. Drug Des Devel Ther (2016) 0.75
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (1990) 8.07
Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci (2001) 6.86
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci (2007) 4.93
The basal ganglia and adaptive motor control. Science (1994) 4.27
A cellular mechanism of reward-related learning. Nature (2001) 4.09
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol (2004) 3.84
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry (2005) 3.74
Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci (2007) 3.64
The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol (2005) 3.28
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci (1992) 3.10
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry (1992) 2.84
Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron (2006) 2.79
D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci (2009) 2.65
DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53
Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. J Neurosci (2008) 2.50
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell (1994) 2.46
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J Neurosci (2007) 2.11
Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem (2006) 1.77
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis (2004) 1.65
Modulation of D2R-NR2B interactions in response to cocaine. Neuron (2006) 1.62
L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. J Neurochem (2009) 1.53
Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry (2009) 1.44
Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res (2000) 1.25
Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat (2006) 1.25
Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J Neurosci (2004) 1.23
Parkinson's disease: levodopa-induced dyskinesia and signal transduction. FEBS J (2008) 1.22
The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice. Psychopharmacology (Berl) (2001) 1.15
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci (2005) 1.13
Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J Neurosci (2008) 1.11
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Exp Neurol (2005) 1.11
The DARPP-32 knockout mouse. Brain Res Brain Res Rev (2000) 1.00
D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease. Neuroscientist (2003) 1.00
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2003) 12.94
Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci (2006) 12.37
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science (2006) 9.31
Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci (2005) 9.17
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
A translational profiling approach for the molecular characterization of CNS cell types. Cell (2008) 8.69
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci (2006) 8.24
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature (2011) 7.90
Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell (2008) 7.74
The molecular neurobiology of depression. Nature (2008) 6.51
Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci (2007) 6.00
The many faces of CREB. Trends Neurosci (2005) 5.58
Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science (2010) 5.48
Dichotomous dopaminergic control of striatal synaptic plasticity. Science (2008) 5.47
Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron (2005) 5.09
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron (2007) 4.96
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci (2007) 4.93
Modulation of striatal projection systems by dopamine. Annu Rev Neurosci (2011) 4.84
New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci (2006) 4.62
GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol (2003) 4.60
Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci (2003) 4.60
Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med (2007) 4.48
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature (2010) 4.07
TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron (2008) 4.00
Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science (2010) 3.97
Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A (2007) 3.92
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol (2004) 3.84
Psychobiology and molecular genetics of resilience. Nat Rev Neurosci (2009) 3.71
Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci (2011) 3.69
Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci U S A (2006) 3.68
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
Alterations in 5-HT1B receptor function by p11 in depression-like states. Science (2006) 3.55
Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci (2008) 3.50
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci (2010) 3.47
Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci (2010) 3.41
Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A (2004) 3.37
CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A (2002) 3.32
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol (2002) 3.23
Decoding the epigenetic language of neuronal plasticity. Neuron (2008) 3.23
Antidepressant actions of histone deacetylase inhibitors. J Neurosci (2009) 3.17
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature (2012) 3.15
The brain reward circuitry in mood disorders. Nat Rev Neurosci (2013) 3.08
Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci (2004) 3.05
The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci (2010) 3.02
Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron (2008) 3.01
Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron (2009) 2.97
CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci (2006) 2.95
Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A (2005) 2.95
Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93
Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron (2007) 2.93
Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron (2010) 2.92
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci (2010) 2.84
IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab (2012) 2.80
Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature (2010) 2.80
Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature (2006) 2.77
IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci (2006) 2.71
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis (2005) 2.70
DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res (2004) 2.67
The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci (2008) 2.64
RGS9 modulates dopamine signaling in the basal ganglia. Neuron (2003) 2.61
Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry (2010) 2.54
Diverse psychotomimetics act through a common signaling pathway. Science (2003) 2.52
ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol (2006) 2.50
Gleevec inhibits beta-amyloid production but not Notch cleavage. Proc Natl Acad Sci U S A (2003) 2.44
Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry (2003) 2.37
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry (2006) 2.36
Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35
Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci (2008) 2.34
Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A (2003) 2.32
Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci (2004) 2.30
DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci (2006) 2.29
Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci (2008) 2.29
Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci (2004) 2.27
Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron (2009) 2.26
Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci (2009) 2.25
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci (2002) 2.21
Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat Neurosci (2012) 2.20
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci (2009) 2.18
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A (2010) 2.17
An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci (2006) 2.17
Molecular neurobiology of drug addiction. Annu Rev Med (2004) 2.16
Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci (2003) 2.16
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci (2007) 2.15
IκB kinase regulates social defeat stress-induced synaptic and behavioral plasticity. J Neurosci (2011) 2.15
Epigenetic mechanisms in drug addiction. Trends Mol Med (2008) 2.14